HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ian D Poulton Selected Research

Proteins (Proteins, Gene)

1/2018Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP.
1/2017Probability of Transmission of Malaria from Mosquito to Human Is Regulated by Mosquito Parasite Density in Naïve and Vaccinated Hosts.
9/2016Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP.
4/2015Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals.
12/2014Combining viral vectored and protein-in-adjuvant vaccines against the blood-stage malaria antigen AMA1: report on a phase 1a clinical trial.
12/2011Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors.
1/2011Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ian D Poulton Research Topics

Disease

19Malaria
05/2022 - 01/2011
13Infections
05/2022 - 01/2011
6Bites and Stings (Sting)
12/2021 - 12/2012
5Falciparum Malaria (Plasmodium falciparum Malaria)
11/2017 - 12/2011
4Parasitemia
05/2022 - 06/2016
4Tuberculosis (Tuberculoses)
04/2014 - 04/2012
1Vivax Malaria
05/2022
1Parasitic Diseases (Parasitic Disease)
09/2016
1Vaccinia
09/2016
1Neglected Diseases
12/2014
1Human Influenza (Influenza)
02/2013
1Communicable Diseases (Infectious Diseases)
01/2013
1HIV Infections (HIV Infection)
01/2011

Drug/Important Bio-Agent (IBA)

23VaccinesIBA
05/2022 - 01/2011
81- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA
05/2022 - 01/2013
7Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2011
6AntigensIBA
01/2018 - 12/2011
3AntibodiesIBA
01/2017 - 12/2012
2ThrombospondinsIBA
01/2018 - 09/2016
2Malaria VaccinesIBA
09/2016 - 12/2012
2Recombinant ProteinsIBA
12/2014 - 01/2012
2MVA 85AIBA
01/2013 - 01/2011
2Merozoite Surface Protein 1 (MSA1)IBA
12/2012 - 12/2011
1Pharmaceutical PreparationsIBA
12/2021
1EpitopesIBA
01/2018
1Aluminum Hydroxide (Algeldrate)FDA Link
12/2014
1AluminumIBA
12/2014
1ProMune (CpG 7909)IBA
12/2014
1Antimalarials (Antimalarial Agents)IBA
01/2013
1Subunit VaccinesIBA
01/2013
1RNA (Ribonucleic Acid)IBA
01/2011